Mark S. Berger
Equibles does not estimate personal net worth.
About Mark S. Berger
The proxy statement of Actinium Pharmaceuticals, Inc. reports total compensation of $584,357 for Mark S. Berger in fiscal 2021, including a base salary of $304,962. Disclosed compensation is on record for 4 fiscal years.
Affiliation history
-
Actinium Pharmaceuticals, Inc. (ATNM)
Proxy statement
Start not stated–2021-10-18
Last confirmed by a filing; no departure on record
-
Actinium Pharmaceuticals, Inc. (ATNM)
Proxy statement
Start not stated–2021-09-24
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Actinium Pharmaceuticals, Inc. (ATNM) | Former Chief Medical Officer | $304,962 | $584,357 |
| 2020 | Actinium Pharmaceuticals, Inc. (ATNM) | Former Chief Medical Officer | $415,000 | $829,958 |
| 2019 | Actinium Pharmaceuticals, Inc. (ATNM) | Chief Medical Officer | $405,000 | $554,364 |
| 2018 | Actinium Pharmaceuticals, Inc. (ATNM) | Chief Medical Officer | $400,000 | $612,313 |
Recent activity
No call appearances or filed executive changes recorded yet.